The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography.
Open accessAbstract
Skeletal muscle sensitivity and responsiveness to insulin and their relationship to overall glucose disposal and insulin binding were determined in 89 premenopausal women of varying body fat topography (waist/hips girth ratio [WHR] 0.64-1.02) and obesity level (percentage of ideal body weight 92-230). As a marker of insulin action, the percentage of total glycogen synthase present in the I form (glucose-6-phosphate independent) was measured in quadriceps muscle biopsies. The increase in percentage of synthase I 1 h after oral glucose loading was not significantly different between nonobese and obese weight-matched subgroups of increasing WHR, but this response was maintained at the expense of increasing plasma insulin levels as the WHR rose. The increase in percentage of synthase I in response to submaximal steady state plasma insulin (SSPI) of approximately 100 microU/ml achieved by the infusion of somatostatin, insulin, and glucose, however, was significantly lower in obese than in nonobese subjects, and was inversely correlated with WHR. The increase in percentage of synthase I correlated inversely with the steady state plasma glucose (SSPG) concentration, which is an index of the efficiency of overall glucose disposal, and directly with insulin binding to circulating monocytes. Insulin binding also correlated inversely with WHR and with fasting plasma insulin levels. When obese subjects were separated into three weight-matched subgroups on the basis of increasing WHR, significant trends to decreased percentage of synthase I response, increased SSPG, and decreased insulin binding were found. In women with predominantly upper body obesity (WHR greater than 0.85), the increase in percentage of synthase in response to submaximal SSPI was diminished, but there was no impairment of percentage of synthase I responsiveness to supramaximal SSPI of approximately 1,000 microU/ml. At supramaximal SSPI levels, SSPG in four obese women was normal, whereas in five women, SSPG concentrations were markedly increased. Our results suggest that in premenopausal women, impaired skeletal muscle insulin sensitivity that results in decreased glucose storage capacity may contribute to the diminished efficiency of glucose disposal and insulin resistance that are associated with upper body obesity. The impairment in skeletal muscle sensitivity may be overcome in vivo at the expense of increasing plasma insulin levels, with maximal responsiveness remaining unimpaired. This defect may result from a reduction in insulin receptor number which could, in turn, be secondary to persistently elevated fasting plasma insulin levels. In some upper body segment obese women, however, an additional defect affecting other insulin-sensitive pathways may also be present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Insulin Binding to Monocytes and Insulin Action in Human Obesity, Starvation, and Refeeding
Defronzo, R. A., Soman, V., Sherwin, R. S., Hendler, R., & Felig, P. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109108 · Cited by 252
RetractedRandle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
Kolterman, O. G., Insel, J., Saekow, M., & Olefsky, J. M. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109790 · Cited by 664
Bergström, J., Hultman, E., & Roch-Norlund, A. E. (1972) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517209081080 · Cited by 99
Relationship between in Vivo Insulin Resistance and Decreased Insulin Receptors in Obese Man*
KOLTERMAN, O. G., REAVEN, G. M., & OLEFSKY, J. M. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-3-487 · Cited by 85
Cited by
Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Fujioka, S., Matsuzawa, Y., Tokunaga, K., & Tarui, S. (1987) · Metabolism · doi:10.1016/0026-0495(87)90063-1 · Cited by 1,207
Kelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Lillioja, S., Young, A. A., Culter, C. L., Ivy, J. L., Abbott, W. G., Zawadzki, J. K., Yki-Järvinen, H., Christin, L., Secomb, T. W., & Bogardus, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113088 · Cited by 782
Relationships of generalized and regional adiposity to insulin sensitivity in men.
Abate, N., Garg, A., Peshock, R. M., Stray-Gundersen, J., & Grundy, S. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118083 · Cited by 759
The perils of portliness: causes and consequences of visceral adiposity.
Montague, C. T., & O'Rahilly, S. (2000) · Diabetes · doi:10.2337/diabetes.49.6.883 · Cited by 737
Goodpaster, B. H., Thaete, F. L., & Kelley, D. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.4.885 · Cited by 707
Influence of body fat distribution on free fatty acid metabolism in obesity.
Jensen, M. D., Haymond, M. W., Rizza, R. A., Cryer, P. E., & Miles, J. M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113997 · Cited by 683
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
SACCÀ, L., CITTADINI, A., & FAZIO, S. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-5-555 · Cited by 543
The metabolic syndrome and adipocytokines
Matsuzawa, Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.028 · Cited by 542
Insulin resistance is a characteristic feature of primary hypertension independent of obesity
Pollare, T., Lithell, H., & Berne, C. (1990) · Metabolism · doi:10.1016/0026-0495(90)90071-j · Cited by 530
Simoneau, J., Veerkamp, J. H., Turcotte, L. P., & Kelley, D. E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.2051 · Cited by 491
Nonlinear dynamics of multi-omics profiles during human aging
Shen, X., Wang, C., Zhou, X., Zhou, W., Hornburg, D., Wu, S., & Snyder, M. P. (2024) · Nature Aging · doi:10.1038/s43587-024-00692-2 · Cited by 500
Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease
Matsuzawa, Y. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0380 · Cited by 434
Biology of regional body fat distribution: Relationship to non‐insulin‐dependent diabetes mellitus
Kissebah, A. H., & Peiris, A. N. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050202 · Cited by 389
Self-citationDownregulation of Adipose Tissue Fatty Acid Trafficking in Obesity
McQuaid, S. E., Hodson, L., Neville, M. J., Dennis, A. L., Cheeseman, J., Humphreys, S. M., Ruge, T., Gilbert, M., Fielding, B. A., Frayn, K. N., et al. (2011) · Diabetes · doi:10.2337/db10-0867 · Cited by 366
“An expansion of adipose tissue mass, in particular abdominal obesity, is associated with an increased risk of type 2 diabetes (1), cardiovascular disease (2), insulin resistance (3), and all-cause mortality (4,5).”
BackgroundInsulin resistance and breast‐cancer risk
Bruning, P. F., Bonfrèr, J. M. G., van Noord, P. A. H., Hart, A. A. M., de Jong‐Bakker, M., & Nooijen, W. J. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520402 · Cited by 361
Obesity and insulin resistance in humans: A dose-response study
Bonadonna, R. C., Leif, G., Kraemer, N., Ferrannini, E., Prato, S. D., & DeFronzo, R. A. (1990) · Metabolism · doi:10.1016/0026-0495(90)90002-t · Cited by 355
Splanchnic insulin metabolism in obesity. Influence of body fat distribution.
Peiris, A. N., Mueller, R. A., Smith, G. A., Struve, M. F., & Kissebah, A. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112758 · Cited by 346
Self-citationCaro, J. F., Sinha, M. K., Raju, S. M., Ittoop, O., Pories, W. J., Flickinger, E. G., Meelheim, D., & Dohm, G. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112958 · Cited by 341
Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease.
Stern, M. P., & Haffner, S. M. (1986) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.6.2.123 · Cited by 331
Number of Pregnancies and the Subsequent Risk of Cardiovascular Disease
Ness, R. B., Harris, T., Cobb, J., Flegal, K. M., Kelsey, J. L., Balanger, A., Stunkard, A. J., & D'Agostino, R. B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305273282104 · Cited by 316
Kissebah, A. H., Freedman, D. S., & Peiris, A. N. (1989) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30695-2 · Cited by 311
Self-citationDohm, G. L., Tapscott, E. B., Pories, W. J., Dabbs, D. J., Flickinger, E. G., Meelheim, D., Fushiki, T., Atkinson, S. M., Elton, C. W., & Caro, J. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113622 · Cited by 296
Caprio, S., Hyman, L., McCarthy, S., Lange, R., Bronson, M., & Tamborlane, W. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.1.12 · Cited by 288
Comorbidities of overweight and obesity: current evidence and research issues
PI-SUNYER, F. X. (1999) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199911001-00019 · Cited by 268
Effects of body fat distribution on regional lipolysis in obesity.
Martin, M. L., & Jensen, M. D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115345 · Cited by 252
Freidenberg, G. R., Henry, R. R., Klein, H. H., Reichart, D. R., & Olefsky, J. M. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112789 · Cited by 234
Fat content in individual muscle fibers of lean and obese subjects.
Malenfant, P., Joanisse, D., Thériault, R., Goodpaster, B., Kelley, D., & Simoneau, J.-A. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801733 · Cited by 227
Damsbo, P., Vaag, A., Hother-Nielsen, O., & Beck-Nielsen, H. (1991) · Diabetologia · doi:10.1007/bf00405082 · Cited by 203
Obesity and insulin resistance: Lessons learned from the Pima indians
Lillioja, S., & Bogardus, C. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040508 · Cited by 203
Mandarino, L. J., Wright, K. S., Verity, L. S., Nichols, J., Bell, J. M., Kolterman, O. G., & Beck-Nielsen, H. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113118 · Cited by 194
“In muscle, glycogen synthase (GS) is activated by its allosteric effector G6P (4, 5) and in human muscle is dephosphorylated and activated by insulin infusion (6-9).”
BackgroundResultOkosun, I. S., Liao, Y., Rotimi, C. N., Prewitt, T. E., & Cooper, R. S. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(00)00045-4 · Cited by 193
Després, J., & LAMARCHE, B. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01114.x · Cited by 164
Ferrara, C. M., Goldberg, A. P., Ortmeyer, H. K., & Ryan, A. S. (2006) · The Journals of Gerontology: Series A · doi:10.1093/gerona/61.5.480 · Cited by 136
Grunfeld, C., Rimland, D., Gibert, C. L., Powderly, W. G., Sidney, S., Shlipak, M. G., Bacchetti, P., Scherzer, R., Haffner, S. M., & Heymsfield, S. B. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31814b94e2 · Cited by 114
“As a consequence, the use of a waist-to-hip ratio (WHR) became a marker for what was referred to as central or upper body obesity.(2,4,5) The recognition of the metabolic differences between visceral and subcutaneous fat provided a basis for the association of central or upper body obesity and insulin resistance.”
BackgroundLILLIOJA, S., MOTT, D. M., ZAWADZKI, J. K., YOUNG, A. A., ABBOTT, W. G., & BOGARDUS, C. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-922 · Cited by 111
Is Obesity an Underlying Factor in Erectile Dysfunction?
Chung, W. S., Sohn, J. H., & Park, Y. Y. (1999) · European Urology · doi:10.1159/000019929 · Cited by 106
“The data of the present study clearly show that obese men complain of having a lesser degree of penile rigidity in spontaneous erectile quality and a higher incidence of vascular impairment in their penile hemodynamics than nonobese men. However, when we only look at patients who did not have any vascular risk factors…”
BackgroundDevelopment of hyperinsulinemia and insulin resistance during the early stage of weight gain
Erdmann, J., Kallabis, B., Oppel, U., Sypchenko, O., Wagenpfeil, S., & Schusdziarra, V. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00560.2007 · Cited by 103
Okosun, I., Tedders, S., Choi, S., & Dever, G. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801414 · Cited by 101
Goldfine, A. B., Bouche, C., Parker, R. A., Kim, C., Kerivan, A., Soeldner, J. S., Martin, B. C., Warram, J. H., & Kahn, C. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438009100 · Cited by 99
Golay, A., DeFronzo, R. A., Ferrannini, E., Simonson, D. C., Thorin, D., Acheson, K., Thi�baud, D., Curchod, B., J�quier, E., & Felber, J. P. (1988) · Diabetologia · doi:10.1007/bf00264764 · Cited by 91
Tripathy, D., Eriksson, K. F., Orho-Melander, M., Fredriksson, J., Ahlqvist, G., & Groop, L. (2004) · Diabetologia · doi:10.1007/s00125-004-1393-8 · Cited by 74
METABOLIC COMPLICATIONS OF OBESITY
Sheehan, M. T., & Jensen, M. D. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70226-1 · Cited by 68
Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance
Blaak, E. E. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.04.001 · Cited by 57
Metadata
- Authors
- Evans, D. J., Murray, R., & Kissebah, A. H.
- Venue
- Journal of Clinical Investigation
- Published
- 1984-10-01
- Volume
- 74
- Issue
- 4
- Pages
- 1515-1525
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2096992905
- Cited by
- 201
- References
- 6
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.